Oulu-based Health & Life Science company, Finnadvance, joined the Teknologia 23 startup competition and returned home with an honourable mention.
The competition was held in cooperation with the Finnish Business Angels Network (FiBAN) already for the third time. The jury selected six innovative solutions for the finals from the pool of twenty health start-ups. Finnadvance was recognised for its organic chips that enable personalized medicines. The goal of the platform developed by Finnadvance is to speed up drug development and enable individualized drugs that are best suited for each individual. The platform is based on chips formed from human tissues grown in the laboratory. The technology can replace animal experiments and pave the way for personalized medicine and a sustainable future in medicine.